Nemaura Medical Inc
General ticker "NMRD" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $4.2K
Nemaura Medical Inc does not follow the US Stock Market performance with the rate: -43.5%.
Estimated limits based on current volatility of 53.3%: low 0.00$, high 0.00$
Factors to consider:
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-03-31 to 2025-03-30
- 2023-03-31 to 2024-03-30 estimated range: [0.41$, 1.36$]
- 2024-03-30 to 2025-03-30 estimated range: [0.30$, 0.97$]
Financial Metrics affecting the NMRD estimates:
- Negative: Non-GAAP EPS, $ of -0.56 <= 0.10
- Negative: Operating profit margin, % of -99.20 <= 1.03
- Negative: Operating cash flow per share per price, % of -28.43 <= 2.35
- Negative: negative Net income
- Negative: Inventory ratio change, % of 24.58 > 1.08
- Negative: Industry earnings per price (median), % of -5.20 <= 1.31
- Negative: Industry operating cash flow per share per price (median), % of -6.88 <= 3.85
Short-term NMRD quotes
Long-term NMRD plot with estimates
Financial data
| YTD | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.50MM | $0.08MM |
| Operating Expenses | $4.59MM | $8.07MM | $9.67MM |
| Operating Income | $-4.59MM | $-7.57MM | $-9.60MM |
| Non-Operating Income | $-2.01MM | $-6.67MM | $-4.55MM |
| Interest Expense | $2.01MM | $6.67MM | $6.41MM |
| R&D Expense | $1.55MM | $1.56MM | $1.54MM |
| Income(Loss) | $-6.59MM | $-14.24MM | $-14.14MM |
| Taxes | $-0.34MM | $-0.35MM | $0.00MM |
| Profit(Loss) | $-6.26MM | $-13.89MM | $-14.14MM |
| Stockholders Equity | $8.36MM | $0.47MM | $-11.81MM |
| Inventory | $0.85MM | $1.49MM | $1.75MM |
| Assets | $35.24MM | $22.10MM | $14.56MM |
| Operating Cash Flow | $-6.00MM | $-6.50MM | $-8.45MM |
| Capital expenditure | $0.84MM | $0.96MM | $0.54MM |
| Investing Cash Flow | $-0.84MM | $-0.96MM | $-0.54MM |
| Financing Cash Flow | $37.99MM | $-6.37MM | $2.08MM |
| Earnings Per Share* | $-0.28 | $-0.59 | $-0.57 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.